MedPath

Comparison of intravenous Magnesium sulfate and intravenous Tramadol for prevention of post spinal shivering in patients undergoing lower limb Orthopedic surgery.

Not yet recruiting
Conditions
Disorder of continuity of bone, unspecified, (2) ICD-10 Condition: M849||Disorder of continuity of bone, unspecified, (3) ICD-10 Condition: M849||Disorder of continuity of bone, unspecified,
Registration Number
CTRI/2021/06/034048
Lead Sponsor
Satyajeet Singh
Brief Summary

Shivering being one of the most common complication of spinal anesthesia, we want to compare the efficacy of intravenous Magnesium sulfate with intravenous Tramadol on patients undergoing lower limb orthopaedic surgeries under spinal anaesthesia for postspinal shivering. The purpose of study to find the most efficient drug among them.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
75
Inclusion Criteria
  • 1.American Society of Anesthesiologists’ Physical Status I & II.
  • 2.Patients posted for lower limb orthopaedic surgery under spinal anesthesia in Peoples Hospital.
Exclusion Criteria
  • 1.American Society of Anesthesiologists’ physical Status III & IV.
  • 2.Patients with Severe cardiopulmonary, renal or liver disease 3.Morbidly obese patients 4.Basal body temperature of patiens >38°C or <36°C 5.Those who received blood transfusion or >2500 ml fluid 6.Patients Allergic to study drug 7.Patients refusing to give consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tramadol and Magnesium sulfate both are equally effective in postspinal shivering.1 hour
Secondary Outcome Measures
NameTimeMethod
Tramadol and Magnesium sulfate both are equally effective in postspinal shivering.1 hour

Trial Locations

Locations (1)

Peoples Hospital

🇮🇳

Bhopal, MADHYA PRADESH, India

Peoples Hospital
🇮🇳Bhopal, MADHYA PRADESH, India
Satyajeet Singh
Principal investigator
8959257243
satya_jeet97@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.